2 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Azur Pharma, Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder Fazaclo - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | Manhattan Psychiatric Center | 20 | 2006-11-01 | 2015-04-15 |
| FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey FazaClo (clozapine, USP) ODT - Weight Gain, Sialorrhea | Completed | Azur Pharma, Inc | 2008-06-19 |
Psychotic Disorders (1) · Schizophrenia (1) · Schizophrenia, Treatment-Resistant (1) · Sialorrhea (1) · Weight Gain (1)
Clozapine (2)
United States (2)